Trial Profile
A Prospective, Open-Label Assessment of the Albuterol Spiromax DPI Integrated Dose Counter
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D; Teva Pharmaceutical Industries
- 17 May 2017 According to a Teva Pharmaceutical media results, data from this study will be presented at 2017 American Thoracic Society (ATS) International Conference.
- 10 Aug 2015 New trial record